Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells

Fbxo7 is associated with cancer and Parkinson’s disease. Although Fbxo7 recruits substrates for SCF-type ubiquitin ligases, it also promotes Cdk6 activation in a ligase-independent fashion. We discovered PFKP, the gatekeeper of glycolysis, in a screen for Fbxo7 substrates. PFKP is an essential Cdk6...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Rebecca, Yang, Ming, Schmidt, Christina, Royet, Chloe, Singh, Sarbjit, Natarajan, Amarnath, Morris, May, Frezza, Christian, Laman, Heike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178409/
https://www.ncbi.nlm.nih.gov/pubmed/35670764
http://dx.doi.org/10.1083/jcb.202203095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178409/
https://www.ncbi.nlm.nih.gov/pubmed/35670764
http://dx.doi.org/10.1083/jcb.202203095

Ejemplares similares